Cas:91394-66-0 N-(4-Bromonaphthalen-1-yl)acetamide manufacturer & supplier

Chemical Name:N-(4-Bromonaphthalen-1-yl)acetamide

CAS.NO:91394-66-0

Synonyms:N-(4-bromonaphthalen-1-yl)acetamide

Molecular Formula:C₁₂H₁₀BrNO

Molecular Weight:264.11800

HS Code:2924299090

Physical and Chemical Properties:

Melting point:160-163ºC

Boiling point:454.3ºC at 760 mmHg

Density:1.528 g/cm3

Index of Refraction:1.69

PSA:29.10000

Exact Mass:262.99500

LogP:3.63370

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-(4-bromonaphthalen-1-yl)acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(4-bromonaphthalen-1-yl)acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(4-bromonaphthalen-1-yl)acetamide Use and application,N-(4-bromonaphthalen-1-yl)acetamide technical grade,usp/ep/jp grade.

Related News: In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. N-(4-Bromonaphthalen-1-yl)acetamide manufacturer The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. N-(4-Bromonaphthalen-1-yl)acetamide supplier In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. N-(4-Bromonaphthalen-1-yl)acetamide vendor US citizens who’ve been in other parts of mainland China in the last 14 days will undergo screening at US ports of entry and up to 14 days of self-monitoring. N-(4-Bromonaphthalen-1-yl)acetamide factory The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions.